Meglife Pharmaceuticals Private Limited
About Meglife Pharmaceuticals Private Limited
Data last updated:
Meglife Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the support services segment of the services sector. It was incorporated on 28 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U52310TN2011PTC079890. Its GSTIN is 33AAHCM0991L1Z7 (Tamil Nadu).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prince Jacob and Roseline Thomas.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.7 Gangai Amman Koil Street Jafferkhanpet, Chennai, Tamil Nadu, India – 600083.
As per the financials filed for FY 2025, the company reported a revenue of ₹60.21 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹40,838 (net margin 0.7%) and EBITDA of ₹60,469 (EBITDA margin 1%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 5% over five years.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Meglife Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.7 Gangai Amman Koil Street Jafferkhanpet, Chennai, Tamil Nadu, India – 600083
- IndustryService, Other Support Services
To see the full contact details of Meglife Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Meglife Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Meglife Pharmaceuticals Private Limited, buy the company report.
Financials of Meglife Pharmaceuticals Private Limited
FY 2025 filings availableMeglife Pharmaceuticals Private Limited reported revenue of ₹60.21 Lakh (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹60,469 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹40,838 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Meglife Pharmaceuticals Private Limited, buy the company report.
Board of directors of Meglife Pharmaceuticals Private Limited
Meglife Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prince Jacob | Director | 28 Mar 2011 | 15 Years 7 Months | Current |
| Roseline Thomas | Director | 28 Mar 2011 | 15 Years 7 Months | Current |
Peer comparison
Meglife Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| VNH Pharmaceuticals Private Limited | ₹60.62 Lakh (FY 2021) | -38.0% | Shameerpet, Telangana, India | |||
| Meglife Pharmaceuticals Private Limitedthis company | ₹60.21 Lakh (FY 2025) | ₹40,838 | 0.7% | 3.0% | Chennai, Tamil Nadu, India | |
| Oberto Pharmaceuticals Private Limited | ₹60.15 Lakh (FY 2020) | 266.0% | Manimajra, Chandigarh, India | |||
| Dewey Pharmaceuticals Private Limited | ₹60.03 Lakh (FY 2024) | 60.0% | Guwahati, Assam, India |
To see the full peer comparison of Meglife Pharmaceuticals Private Limited, buy the company report.
Auditor
Meglife Pharmaceuticals Private Limited is audited by A.Kaliannan & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A.Kaliannan & Associates | FY 2017 | 011675S |
Shareholding
The shareholding of Meglife Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Meglife Pharmaceuticals Private Limited, buy the company report.
Legal cases
Meglife Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Puducherry | Civil suit | Filed against the company by M/S. Nanoceut Therapeutics Pvt. Ltd., Rep. by Its Authorised Signatory, Somasundaram | Disposed |
To see the full case history of Meglife Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Meglife Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Meglife Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAHCM0991L1Z7 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Meglife Pharmaceuticals Private Limited, buy the company report.
Recent activity
Meglife Pharmaceuticals Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Prince Jacob was appointed as Director on 28 Mar 2011.
Frequently asked questions
Meglife Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in other support services, within the service industry. It was incorporated on 28 March 2011 (15+ years old) and is registered under CIN U52310TN2011PTC079890.
Meglife Pharmaceuticals has 2 current directors:
- Prince Jacob - Director
- Roseline Thomas - Director
The latest financial statements of Meglife Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Meglife Pharmaceuticals is 33AAHCM0991L1Z7, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Meglife Pharmaceuticals is U52310TN2011PTC079890. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meglife Pharmaceuticals has 1 court case on record: 1 filed against it.
Meglife Pharmaceuticals was incorporated on 28 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Meglife Pharmaceuticals by revenue are VNH Pharmaceuticals Private Limited, Oberto Pharmaceuticals Private Limited, Dewey Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Prince Jacob was appointed as Director on 28 Mar 2011. Roseline Thomas was appointed as Director on 28 Mar 2011.
The registered office of Meglife Pharmaceuticals is at No.7 Gangai Amman Koil Street Jafferkhanpet, Chennai, Tamil Nadu, India – 600083.
Meglife Pharmaceuticals operates in the service industry, in the other support services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
